Evidence map›Paper›PMID 12085240›Full record

ArticleGene therapy2002

Apical barriers to airway epithelial cell gene transfer with amphotropic retroviral vectors.

G Wang, G Williams, H Xia, M Hickey, J Shao, B L Davidson, P B McCray

Open access · bronzeAbstract read
In one paragraph

Article in Gene therapy, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Cancer gene discovery in mouse and man.Biochimica et biophysica acta · 2009
    Review
  2. Article
  3. Review
  4. Article
  5. Identification of glycosaminoglycans in human airway secretions.American journal of respiratory cell and molecular biology · 2006
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

G WangProgram in Gene Therapy, Department of Pediatrics, University of Iowa College of Medicine, Iowa City, IA 52242, USA.
G Williams
H Xia
M Hickey
J Shao
B L Davidson
P B McCray
University of Iowa · US

Funding

Vector CoreP01HL051670 · NHLBI · UNIVERSITY OF IOWA · PI MCCRAY, PAUL B · 1993 to 2019
$36.5M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Alejandro Antonio Pezzulo · 1998 to 2026
$30.5M
Retrograde amnesia after hippocampal damageR01MH061460 · NIMH · UNIVERSITY OF LETHBRIDGE · PI SUTHERLAND, ROBERT JAMES · 2002 to 2006
$799k
RETROVIRUS MEDIATED GENE TRANSFER TO AIRWAY EPITHELIAR01HL061460 · NHLBI · UNIVERSITY OF IOWA · PI MCCRAY, PAUL B · 1999 to 2002
$378k
NHLBI NIH HHS P01 HL051670NHLBI NIH HHS P50 HL51670NHLBI NIH HHS R01 HL61460NIDDK NIH HHS P30 DK054759NIDDK NIH HHS P30 DK54759NIMH NIH HHS R01 MH061460
6 · The paper itself

Abstract

Gene transfer to airway epithelia with amphotropic pseudotyped retroviral vectors is inefficient following apical vector application. To better understand this inefficiency, we localized the expression of Pit2, the amphotropic receptor, in polarized human airway epithelia. Pit2 was expressed on both the apical and basolateral surfaces of the cells, suggesting that factors other than receptor abundance may limit apical gene transfer efficiency. Binding studies performed with radiolabeled amphotropic MuLV suggested that the apically applied virus binds to Pit2. Hypothetical barriers to retroviral gene transfer include the apical glycocalyx and other secreted products of epithelia. In this study, we demonstrated that sialic acid, keratan sulfate and collagen type V are present on the apical surface of well-differentiated human airway epithelia. While enzyme treatment reduced the abundance of these components, the treatment also decreased the transepithelial resistance to approximately 35% of the controls, suggesting that the epithelial integrity was impaired. To attain an airway epithelial culture with a modified apical surface and intact epithelial integrity, we utilized 100 mM 2-deoxy-D-glucose, a glycosylation inhibitor, to prevent the glycocalyx from reforming following enzyme treatment. This approach allowed the resistance, but not the apical glycocalyx to recover. Despite this physical modification of the cell surface, the amphotropic retroviral vector failed to transduce airway epithelia following apical application. These results suggest that factors other than apical receptor abundance and the glycocalyx inhibit amphotropic retroviral gene transfer in human airway epithelia.

Indexed as

beta-GalactosidaseCell PolarityCells, CulturedCystic FibrosisDNA-Binding ProteinsEpithelial CellsGenetic TherapyGenetic VectorsGlycocalyxHumansMicroscopy, ElectronMicroscopy, Electron, ScanningMoloney murine leukemia virusProtein BindingRespiratory MucosaTranscription Factor Pit-1beta-GalactosidaseDNA-Binding ProteinsPOU1F1 protein, humanTranscription Factor Pit-1Transcription Factors

Identifiers

PMID12085240
PMCPMC7091907
OpenAlexW2326918786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.